Stem cell properties change over time to match the changing growth and regeneration demands of tissues. We showed previously that adult forebrain stem cell function declines during aging because of increased expression of let-7 microRNAs, evolutionarily conserved heterochronic genes that reduce HMGA2 expression. Here we asked whether let-7 targets also regulate changes between fetal and adult stem cells. We found a second let-7 target, the RNA binding protein IMP1, that is expressed by fetal, but not adult, neural stem cells. IMP1 expression was promoted by Wnt signaling and Lin28a expression and opposed by let-7 microRNAs. Imp1-deficient neural stem cells were prematurely depleted in the dorsal telencephalon due to accelerated differentiation, impairing pallial expansion. IMP1 post-transcriptionally inhibited the expression of differentiation-associated genes while promoting the expression of self-renewal genes, including Hmga2. A network of heterochronic gene products including Lin28a, let-7, IMP1, and HMGA2 thus regulates temporal changes in stem cell properties.https://doi.org/10.7554/eLife.00924.001
Stem cells are found throughout the body, and play key roles in promoting tissue growth during fetal development, and in maintaining tissues in the adult. When stem cells divide, they can either give rise to more stem cells, or they can generate specialized cells required for tissue function. However, the properties of stem cells must change over time to match the changing growth and regeneration demands of tissues.
A previous study by Nishino et al. has shown that expression of a micro RNA molecule called let-7 increases throughout adulthood, and this reduces the activity of stem cells in older animals. Now, Nishino et al. report that let-7, and other genes it regulates, also control the dramatic changes that occur in the properties of stem cells between fetal development and adulthood. Whereas stem cells in the fetal forebrain undergo rapid division and are capable of generating many different cell types, stem cells in the adult forebrain divide less often and can generate only a few specific types of cell. While Nishino et al. performed their study on stem cells in the brain, their results are likely to apply also to stem cells in other tissues.
Nishino et al. show that let-7 regulates the production of an RNA binding protein called IMP1. Mice with stem cells that lack IMP1 have a smaller cerebral cortex than normal mice because their stem cells undergo fewer rounds of division before committing to become brain cells. Additional experiments revealed that IMP1 inhibits the expression of genes that trigger stem cells to commit to specific fates and promotes the expression of genes related to self-renewal.
These results indicate that the gene that encodes IMP1 is expressed in fetal neural stem cells, but not in adult neural stem cells, and that the reduced production of this protein contributes to the developmental switch from highly proliferative neural stem cells in the fetus to the more quiescent stem cells found in adults. Further studies are likely to identify many more targets of let-7 that enable stem cells to adapt their properties to the changing needs of the organism over time.
These results are interesting because let-7-regulated networks were first discovered based on their ability to regulate the timing of developmental transitions in worms. This suggests that the mechanisms employed by mammalian tissue stem cells to regulate changes in their properties over time, are at least partly evolutionarily conserved mechanisms inherited from invertebrates.https://doi.org/10.7554/eLife.00924.002
Stem cell properties change throughout life in many tissues in response to changing growth and regeneration demands (He et al., 2009). These changes are particularly evident in the central nervous system (CNS) forebrain, where neural stem cells persist throughout life. During fetal development rapidly dividing neural stem cells expand in number before differentiating in precisely defined temporal windows, first to form neurons and then to form glia (Salomoni and Calegari, 2010). Largely quiescent neural stem cells persist into adulthood in the lateral wall of the lateral ventricle subventricular zone (SVZ) as well as in the dentate gyrus, where they give rise to new interneurons throughout adult life (Alvarez-Buylla and Lim, 2004; Zhao et al., 2008). However, the rate of neurogenesis, the frequency of stem cells, and their rate of proliferation all decline with age (Kuhn et al., 1996; Enwere et al., 2004; Maslov et al., 2004; Molofsky et al., 2006; Bonaguidi et al., 2011; Encinas et al., 2011). A fundamental question concerns the mechanisms that control these temporal changes in stem cell properties.
The declines in SVZ proliferation, stem cell self-renewal potential, and neurogenesis during aging are regulated by a pathway that includes let-7 microRNAs, the chromatin-associated HMGA2 high mobility group protein, and the p16Ink4a cyclin-dependent kinase inhibitor: let-7b expression increases with age, reducing Hmga2 expression and increasing p16Ink4a expression (Nishino et al., 2008). p16Ink4a deficiency or overexpression of a let-7 insensitive form of Hmga2 partially rescues the declines in neural stem cell function and neurogenesis in aging mice (Molofsky et al., 2006; Nishino et al., 2008). This pathway appears to be conserved among multiple mammalian tissues as p16Ink4a deficiency also increases the function of hematopoietic stem cells and pancreatic beta cells during aging (Janzen et al., 2006; Krishnamurthy et al., 2006). HMGA2 also promotes hematopoietic stem cell self-renewal (Cavazzana-Calvo et al., 2010; Ikeda et al., 2011) and myoblast proliferation (Li et al., 2012).
let-7 microRNAs are evolutionarily conserved heterochronic genes that regulate developmental timing (Pasquinelli et al., 2000) and aging (Shen et al., 2012) in Caenorhabditis elegans. In mammals, let-7 microRNAs are known to regulate embryonic stem cells (Melton et al., 2010), primordial germ cells (West et al., 2009), and adult neural stem cells (Zhao et al., 2010) but it is unclear to what extent let-7 targets regulate developmental changes in mammalian stem cell function over time. For example, it is unclear whether the let-7-regulated pathway we identified in aging stem cells only regulates stem cell aging or whether it is one branch of a larger network of heterochronic genes that regulates temporal changes in stem cell function throughout life.
let-7 microRNAs negatively regulate the expression of a number of gene products, including Insulin-like growth factor two mRNA binding protein 1 (IMP1; also known as CRD-BP and VICKZ1) (Boyerinas et al., 2008). IMP1 binds to target RNAs, post-transcriptionally regulating their localization, turnover, and translation (Doyle et al., 1998; Nielsen et al., 1999; Farina et al., 2003; Atlas et al., 2004). Imp1 expression is widespread in fetal tissues but declines perinatally and is not detected in most adult tissues (Hansen et al., 2004; Hammer et al., 2005). Imp1 expression is elevated in several cancers (Ioannidis et al., 2004; Yisraeli, 2005), partly as a consequence of Wnt signaling, which promotes Imp1 transcription (Noubissi et al., 2006; Gu et al., 2008). Over-expression of IMP1 can promote tumorigenesis (Tessier et al., 2004). Imp1 deficient mice have a dwarf phenotype with some neonatal mortality (Hansen et al., 2004). However, it is unknown if IMP1 regulates stem cells.
Canonical Wnt signaling promotes a rapid expansion in the number of undifferentiated stem cells during forebrain development (McMahon et al., 1992; McMahon and Bradley, 1990; Ikeya et al., 1997; Dickinson et al., 1994; Wrobel et al., 2007). Wnt signaling prevents cell cycle exit and delays differentiation in these cells (Megason and McMahon, 2002; Chenn and Walsh, 2002; Machon et al., 2003; Zechner et al., 2003; Zhou et al., 2006; Woodhead et al., 2006; Gulacsi and Anderson, 2008; Wrobel et al., 2007). Wnt signaling also promotes the maintenance of stem cells in the adult forebrain (Kuwabara et al., 2009; Qu et al., 2010). However, it is unclear why Wnt signaling expands the number of neural stem cells during development but only maintains declining numbers of stem cells during adulthood.
Here we report that Imp1 is expressed in fetal neural stem/progenitor cells as a consequence of Wnt signaling but that its expression declines in late fetal development, partly as a consequence of increasing let-7 microRNA expression. Imp1 promoted the expansion of fetal neural stem cells and Imp1 deficiency reduced brain mass. IMP1 bound to a number of mRNAs, post-transcriptionally promoting the expression of gene products that promote self-renewal, including Hmga2, and inhibiting the expression of gene products involved in differentiation. Our findings demonstrate a novel role for IMP1 in the expansion of fetal neural stem cells and suggest that the perinatal loss of IMP1 expression is part of the mechanism that allows Wnt signaling to promote the expansion of fetal stem cells. More broadly, our results demonstrate that a network of heterochronic genes regulates temporal changes in stem cell function throughout life.
We examined Imp1 expression by quantitative RT-PCR (qPCR) in CNS stem/progenitor cells from the embryonic day (E)12.5 dorsal telencephalon, E14.5 dorsal telencephalon, postnatal day (P)0 lateral ventricle ventricular zone (VZ), and P30 lateral ventricle subventricular zone (SVZ). Imp1 expression was high at E12.5 but declined over 100-fold by P0 and was no longer detected in the P30 SVZ (Figure 1A). The family members Imp2 and Imp3 were expressed in patterns very similar to Imp1: high in the telencephalon VZ at E12.5 but declining sharply throughout fetal development (Figure 1—figure supplement 1H,I). This raises the possibility of redundancy among IMP family members during CNS development. In contrast to the Imp1 expression pattern, let-7b expression was very low at E12.5 but increased approximatly 40-fold by P0 and continued to increase into adulthood (Figure 1B). To confirm that let-7b can regulate Imp1, we overexpressed let-7b in neural stem/progenitor cells cultured from E14.5 dorsal telencephalon. IMP1 protein levels were reduced in neurospheres that overexpressed let-7b (Figure 1C). This suggests that Imp1 expression declines as let-7b expression increases during fetal development and that let-7b can inhibit Imp1 expression.
To systematically examine Imp1 expression we analysed a gene-trap mouse (Imp1β-geo/+) in which β-galactosidase-neomycin (β-geo) was inserted into the second intron of Imp1 (Hansen et al., 2004). This led to the expression of an IMP1-β-geo fusion protein that contained the IMP1 RNA recognition motif encoded by exons 1 and 2 but lacked the second RNA recognition motif and the four hnRNP K homology domains, which are essential for biological activity (Nielsen et al., 2002). This mouse therefore provided a loss of function allele that allowed us to monitor Imp1 expression by β-galactosidase activity (Hansen et al., 2004).
At E10.5, Imp1 was expressed throughout the VZ of the entire developing brain with the exception of the floor plate and roof plate (Figure 1—figure supplement 1A). The anatomy of the developing forebrain and the Imp1 expression pattern are schematically summarized in Figure 1—figure supplement 2. At later stages (E12.5-E16.5) Imp1 expression was gradually restricted, mainly to the dorsomedial telencephalon (DMT), where it continued to be expressed by Pax6+ undifferentiated neural stem/progenitor cells in the VZ/SVZ (Figure 1D,E, Figure1—figure supplement 1B). There was little or no Imp1 expression by the differentiated neurons that accumulated at the cortical plate (Figure 1E). At birth, there was little or no Imp1 expression in the cerebral cortex (Figure 1D). In situ hybridization to endogenous Imp1 transcripts revealed a similar expression pattern as observed with X-gal staining of Imp1β-geo/+ mice: Imp1 was mainly expressed in the VZ/SVZ of the dorsal telencephalon at E14.5 and was not detected in P60 hippocampus or olfactory bulb (Figure 1—figure supplement 1E–G).
We cultured cells from E12.5 or P0 cerebral cortex or P60 lateral ventricle SVZ in non-adherent cultures at clonal density. Almost all neurospheres formed by E12.5 Imp1β-geo/+ telencephalon cells, but not littermate control cells, stained with X-gal and this staining was maintained upon passaging of neurospheres (Figure 1F, Figure 1—figure supplement 1C). Immunostaining for β-galactosidase and Nestin co-localized in sections from E12.5 Imp1β-geo/+ neurospheres (Figure 1G). We could not detect X-gal staining in neurospheres cultured from P0 or P60 Imp1β-geo/+ lateral ventricle VZ cells (Figure 1F, Figure 1—figure supplement 1D). Imp1 is therefore expressed in neural stem/progenitor cells in the fetal telencephalon but it’s expression is extinguished postnatally.
Consistent with an earlier report (Hansen et al., 2004), Imp1 deficiency led to growth retardation in mice that was evident by late fetal development and persisted into adulthood (Figure 2—figure supplement 1A,C). The brains of Imp1β-geo/β-geo mice were also significantly (p<0.01) smaller than the brains of littermate controls at P0 and P30 (Figure 2—figure supplement 1B,D). Histological analysis of E18.5 Imp1β-geo/β-geo and littermate control brains showed that pallial expansion was impaired in Imp1β-geo/β-geo brains (Figure 2A). The pial surface from the pallial/subpallial boundary to the retrosplenial cortex, was significantly (p<0.05) shortened in Imp1β-geo/β-geo brains as compared to littermate controls (L in Figure 2A,D). The lateral ventricle was collapsed in Imp1β-geo/β-geo brains, in contrast to littermate controls (Figure 2A). Cortical thickness was not significantly affected by Imp1 deficiency (T in Figure 2A,C). These morphological abnormalities in the cortex first became apparent around E14.5, with a shortened pial surface length, and became increasingly severe throughout the rest of development (Figure 2A,D). At E16.5 and E18.5, the pial surface length was significantly shorter in the Imp1β-geo/β-geo forebrain (Figure 2D) and the lateral ventricle collapsed (Figure 2A).
It is not clear whether the overall growth retardation (Figure 2—figure supplement 1A–D) reflects cell autonomous effects of Imp1 deficiency in stem cells from multiple tissues or whether it reflects non-cell autonomous effects. However, the impaired pallial expansion in the dorsal cortex (Figure 2A) coincided precisely with the domain of Imp1 expression that persisted throughout fetal development (Figure 1D,E; Figure 1—figure supplement 1B, Figure 1—figure supplement 2). We therefore hypothesized that Imp1 is required cell autonomously within stem cells in the dorsal telencephalon to promote pallial expansion, a key event in cortical development.
We examined cells within the dorsal telencephalon in more detail to better understand why pallial expansion was impaired in the absence of Imp1. The number of proliferating cells that incorporated a pulse of BrdU in the VZ did not significantly differ between Imp1β-geo/β-geo and control sections at E12.5 or E14.5 (Figure 2B,E). However, we detected significantly (p<0.05) lower numbers of BrdU+ cells in the VZ of the Imp1β-geo/β-geo dorsomedial telencephalon at E16.5 and E18.5, and in the VZ of Imp1β-geo/β-geo dorsolateral telencephalon at E18.5 (Figure 2B,E). The reduction in proliferating VZ cells was more prominent in dorsomedial telencephalon, where Imp1 is normally strongly expressed, as compared to the dorsolateral telencephalon where Imp1 is more weakly expressed (Figure 2E).
We did not observe any of these effects in Imp1β-geo/+ heterozygous mice (Figure 2E), demonstrating that these effects reflect a loss of IMP1 function rather than a gain-of-function associated with the mutant allele. Moreover, retroviral over-expression of the Imp1-βgeo fusion construct did not significantly affect the size or self-renewal of neurospheres (Figure 2—figure supplement 2A–C).
Apoptotic cells were rare and their numbers were not affected by Imp1 deficiency in the E13.5 or E17.5 telencephalon (Figure 2—figure supplement 1E,F). The reduced proliferation in the dorsal telencephalon appears to reduce pallial expansion in Imp1β-geo/β-geo mice.
To assess whether this prenatal reduction in VZ cell proliferation in the Imp1β-geo/β-geo telencephalon affected the self-renewal potential of individual neural stem cells we cultured cells from E12.5, E15.5, and E18.5 dorsomedial telencephalon from Imp1β-geo/β-geo mice and littermate controls. We cultured the cells at low density in nonadherent cultures and then transferred individual neurospheres to adherent secondary cultures to determine the percentage of telencephalon cells that formed neurospheres that underwent multilineage differentiation. The percentage of cells that formed multipotent neurospheres did not differ between Imp1β-geo/β-geo and wild-type telencephalon at E12.5, but was reduced in Imp1β-geo/β-geo telencephalon at E15.5 and at E18.5 (Figure 2G). Imp1β-geo/β-geo neurospheres did not significantly differ from wild-type neurospheres at E12.5, but were smaller than wild-type neurospheres at E15.5 and E18.5 and formed significantly (p<0.05) fewer multipotent secondary neurospheres upon subcloning (Figure 2F,H). This reduced self-renewal potential was associated with reduced proliferation within Imp1β-geo/β-geo stem cell colonies at E15.5 and E18.5 (Figure 2I). As in vivo, cell death was rare within colonies of both genotypes (Figure 2—figure supplement 1G). The observation that IMP1 promotes the self-renewal of individual neural stem cells in culture demonstrates that IMP1 acts autonomously within neural stem/progenitor cells from the dorsal telencephalon to promote self-renewal.
We also cultured cells from the lateral ventricle SVZ of adult (P60) Imp1β-geo/β-geo mice and littermate controls to assess whether Imp1 deficiency affected the self-renewal of adult neural stem cells. Consistent with our inability to detect Imp1 expression in these cells (Figure 1—figure supplement 1D,F,G), the percentage of cells that formed multipotent neurospheres, neurosphere size, and self-renewal potential did not significantly differ between Imp1β-geo/β-geo and wild-type cells (Figure 2—figure supplement 2D–F).
To assess whether neural stem cell depletion was evident in the Imp1β-geo/β-geo telencephalon in vivo, we examined the number of Pax6+ neural stem cells in the VZ of Imp1β-geo/β-geo mice and littermate controls. The number of Pax6+ cells did not differ among genotypes at E12.5, but was significantly (p<0.05) reduced in the Imp1β-geo/β-geo dorsomedial telencephalon from E14.5 to E18.5 and in the Imp1β-geo/β-geo dorsolateral telencephalon at E18.5 (Figure 3A,B). The percentage of Pax6+ cells that were also BrdU+ or phospho-Histone H3+ (pH3+) did not differ between Imp1β-geo/β-geo and control telencephalon at E12.5 or E14.5, but was significantly (p<0.05) reduced in the Imp1β-geo/β-geo dorsomedial telencephalon at E18.5 (Figure 3A,C, Figure 3—figure supplement 1A,B). Similar to the overall reduction of cell proliferation (Figure 2B,E), the frequencies of Pax6+ cells and Pax6+BrdU+ cells were more strongly reduced in the dorsomedial telencephalon where Imp1 is strongly expressed, as compared to the dorsolateral telencephalon (Figure 3B,C). We did not observe these effects in Imp1β-geo/+ heterozygous mice (Figure 3B,C,E,F), demonstrating that they do not reflect a gain-of-function associated with the mutant allele. Pax6+ neural stem cells therefore become depleted in the Imp1β-geo/β-geo dorsal telencephalon in vivo as a consequence of a loss of IMP1 function.
Complementary to the depletion of Pax6+ stem cells, the number of Tbr2+ intermediate neuronal progenitors was significantly (p<0.01) increased in E12.5 and E14.5 Imp1β-geo/β-geo dorsomedial telencephalon and in E12.5 Imp1β-geo/β-geo dorsolateral telencephalon as compared to littermate controls (Figure 3D,E). This increase in the number of Tbr2+ intermediate neuronal progenitors was transient as it was no longer statistically significant at E18.5 (Figure 3D,E). The increase in the number of Tbr2+ cells was not attributable to increased proliferation by these cells as the percentage of Tbr2+ cells that were also BrdU+ or pH3+ was not significantly different between Imp1β-geo/β-geo and control dorsal telencephalon at E12.5, E14.5, or E18.5 (Figure 3D,F, Figure3—figure supplement 1C,D). This suggests that Pax6+ stem cells are depleted in the absence of IMP1 by precocious maturation into Tbr2+ intermediate progenitors, transiently expanding the number of Tbr2+ cells from E12.5 to E14.5.
The number of Tuj1+ neurons was significantly (p<0.05) increased in the dorsomedial telencephalon of Imp1β-geo/β-geo mice at E12.5 and E14.5 relative to littermate controls (Figure 4A,B). The number of TAG-1+ corticofugal projection neurons was also significantly (p<0.05) increased in the dorsal telencephalon of Imp1β-geo/β-geo mice at E12.5 and E14.5 (not shown). We also dissociated cells from the telencephalons of Imp1β-geo/β-geo mice and littermate controls at E12.5 and cultured them adherently at clonal density. When colonies were stained after 9 days culture, we observed elevated numbers of Tuj1+ neurons within Imp1β-geo/β-geo multilineage colonies as compared to control multilineage colonies (Figure 4C). The frequency of neuron-only colonies formed by Imp1β-geo/β-geo telencephalon cells was also significantly (p<0.05) increased (Figure 4D) but the number of cells within these colonies was not affected (Figure 4E).
Although significant increases in the numbers of Tbr2+ progenitors and Tuj1+ neurons were observed beginning at E12.5 we did not observe a significant depletion of Pax6+ neural stem cells until E14.5. We believe this is because Pax6+ stem cells are much more numerous than Tbr2+ cells and Tuj1+ cells at E12.5. In wild-type mice we counted 617 Pax6+ cells as compared to only 55 Tbr2+ cells and 74 Tuj1+ cells in the same sections (Figure 3B,E and 4B). In Imp1-mutant mice we counted 633 Pax6+ cells as compared to 121 Tbr2+ cells and 117 Tuj1+ cells in the same sections. Therefore, the average increases in Tbr2+ and Tuj1+ cells totalled only 109 cells per section. Given that the standard deviation in Pax6+ cells per section was approximately 100, we were not able to detect such small changes in the number of Pax6+ cells at E12.5. At later stages of development when larger increases in Tbr2+ cells and Tuj1+ cells were observed we did detect significant declines in the numbers of Pax6+ cells.
To test whether Imp1 deficiency also leads to premature gliogenesis, we examined telencephalon sections from Imp1β-geo/β-geo mice and littermate controls at E18.5. The number of GFAP+ astrocytes was significantly increased in the Imp1β-geo/β-geo telencephalon (Figure 4F,G), suggesting that gliogenesis is also precocious in Imp1β-geo/β-geo mice. We also adherently cultured cells from the E18.5 telencephalon of Imp1β-geo/β-geo mice and littermate controls at clonal density. When colonies were stained after 9 days of culture we observed increased numbers of GFAP+ cells within Imp1β-geo/β-geo neural stem cell colonies (Figure 4H). The frequency of glia-only colonies formed by Imp1β-geo/β-geo telencephalon cells was also significantly (p<0.05) increased (Figure 4I) but the number of cells within these colonies was not affected (Figure 4J). The observation that the effects of Imp1 deficiency in vivo are greatest in the dorsal telencephalon where Imp1 expression is highest, and the observation that these effects are also observed when cells are cultured at clonal density, suggest that IMP1 acts autonomously within neural stem cells in the dorsal telencephalon to prevent premature differentiation.
To directly test whether IMP1 acts autonomously within neural stem cells, we injected virus bearing Imp1 shRNA or scrambled control RNA into the telencephalic ventricles of wild-type mice in utero. Infection with the Imp1 shRNA virus, but not the control virus, efficiently reduced IMP1 expression in neurospheres cultured from E14.5 telencephalon (Figure 5A). When these viruses were injected in the telencephalic ventricles of E14.5 wild-type mice in utero and analysed three days later, we distinguished infected from non-infected cells based on GFP expression (which was also carried in the viral vectors) in the dorsal telencephalon. GFP+ cells infected by the control shRNA tended to localize apically, among dividing Pax6+ cells in the VZ/SVZ (Figure 5B, Figure 5—figure supplement 1). In contrast, most GFP+ cells infected by the Imp1 shRNA tended to localize basally, among Tbr2+ and Tuj1+ cells (Figure 5B, Figure 5—figure supplement 1). When cell proliferation was assessed by Ki67+ immunostaining, the percentage of GFP+ cells that were also Ki67+ was significantly (p<0.05) reduced in mice infected with Imp1 shRNA as compared to control shRNA (Figure 5C, Figure5—figure supplment 1). This indicates that Imp1 acts cell autonomously to maintain the proliferation of stem/progenitor cells in the dorsal telencephalon.
To assess whether Imp1 knockdown affects the differentiation of neural stem cells, we injected viruses into the telencephalic ventricles of E12.5 wild-type mice in utero and 3 days later sections were immunostained with antibodies against Pax6, Tbr2 and Tuj1. In mice injected with Imp1 shRNA, significantly fewer GFP+ cells were Pax6+ and significantly more GFP+ cells were Tbr2+ or Tuj1+ as compared to control shRNA (Figure 5D–F). These data indicate that Imp1 acts cell autonomously to maintain Pax6+ stem cells in the dorsal telencephalon by opposing their maturation into Tbr2+ intermediate progenitors and their differentiation into neurons.
The timing of neuronal differentiation by stem/progenitor cells in the telencephalon is regulated by the timing of cell cycle exit, such that over-expression of cyclin D prolongs the proliferation of undifferentiated cells and delays the onset of neurogenesis (Dehay and Kennedy, 2007; Lange et al., 2009). We therefore examined the expression of cell cycle regulators in the dorsal telencephalon of Imp1β-geo/β-geo mice. We observed a significant (*p<0.01; **p<0.05) decline in the levels of all cyclin D family transcripts by both antibody staining (Figure 6A) and qPCR (Figure 6B) in the dorsomedial telencephalon of Imp1β-geo/β-geo mice as compared to control mice (Figure 6A). The decline in cyclin D1 staining was most pronounced in the dorsomedial telencephalon (Figure 6A, arrow) where Imp1 expression was strongest (Figure 6A, arrowhead).
To assess whether increased neurogenesis in the Imp1-deficient telencephalon was associated with accelerated cell cycle exit, E14.5 Imp1β-geo/β-geo and littermate control mice were pulse labeled with BrdU for 24 hr then sacrificed and sections were stained with antibodies against BrdU and Ki67. The fraction of cells that exited the cell cycle during the BrdU pulse was estimated based on the frequency of BrdU+Ki67- cells and the fraction that remained in cycle was estimated based on the frequency of BrdU+Ki67+ cells, as described previously (Chenn and Walsh, 2002). The frequency of BrdU+Ki67- cells was significantly (p<0.05) higher in the Imp1β-geo/β-geo as compared to control telencephalon (Figure 6C), suggesting that cell cycle exit is accelerated in neural stem/progenitor cells from the Imp1β-geo/β-geo telencephalon. We could not detect a significant difference in the number of BrdU+Ki67+ cells. Most BrdU+Ki67+ cells were Pax6+ and most BrdU+Ki67- cells were either Tbr2+ or Tuj1+ (Figure 6D, Figure 6—figure supplement 1). These data suggest that most BrdU+Ki67+ cells were stem/progenitor cells while BrdU+Ki67- cells were a mixture of newborn neurons and neuronal progenitors.
Over-expression of cyclin D1 or cyclin D2 in neural stem/progenitor cells from E18.5 Imp1β-geo/β-geo telencephalon significantly increased Cyclin D1 or Cyclin D2 protein levels and proliferation, and reduced premature glial differentiation by Imp1β-geo/β-geo cells (Figure 6E–G). This suggests that reduced Cyclin D1 or Cyclin D2 expression contributes to the defects in Imp1 deficient neural stem/progenitor cells. IMP1 is therefore required to maintain the expression of proteins that promote progression through G1 phase of the cell cycle such that Imp1 deficiency accelerates cell cycle exit and differentiation.
During corticogenesis, a medial-lateral gradient of canonical Wnt signaling maintains the proliferation of undifferentiated Pax6+ stem cells in the pallial region of the telencephalon, preventing the premature generation of Tbr2+ intermediate progenitors and differentiated neurons (Chenn and Walsh, 2002; Machon et al., 2007; Wrobel et al., 2007; Mutch et al., 2010). The Imp1 expression pattern we observed (Figure 1D and 6A, Figure 1—figure supplement 1B) was reminiscent of the gradient of Wnt signaling observed in the telencephalon (Machon et al., 2007; Mutch et al., 2010); furthermore, the Imp1 loss-of-function phenotype in the telencephalon (Figures 2–6) was reminiscent of the phenotype observed in mutants with reduced Wnt signaling (Mutch et al., 2010). We therefore cultured E12.5 wild-type lateral telencephalon explants for 12 hr with or without recombinant Wnt3a, and examined Imp1 transcript levels by qPCR. Imp1 expression significantly (p<0.01) increased in the presence of Wnt3a (Figure 6—figure supplement 2A). Recombinant Dkk-1, which inhibits Wnt signaling, significantly (p<0.05) reduced Imp1 expression (Figure 6—figure supplement 2A). Addition of BMP4, which also regulates dorsoventral patterning in the telencephalon (Hebert et al., 2003), did not affect Imp1 expression (Figure 6—figure supplement 2A). These observations indicate that Wnt signaling can promote Imp1 expression in neural stem/progenitor cells.
Next we assessed whether TCF4, a transcriptional mediator of canonical Wnt signaling, can directly bind to the Imp1 enhancer/promotor. We did not detect TCF4 binding to exon 6 of Imp1 or to the promoter/enhancer of Lgi4 (negative controls) but did detect TCF4 binding to the first intron of Axin (a positive control [Jho et al., 2002]) (Figure 6—figure supplement 2C). We also examined two putative TCF/Lef binding sites that are conserved across species and located within 3 kb upstream of the Imp1 translational start site (sites A and B in Figure 6—figure supplement 2B). We detected significant enrichment of TCF4 binding at both sites by chromatin immunoprecipitation (Figure 6—figure supplement 2C). Relative luciferase activity was significantly reduced when one of these TCF/Lef binding sites (site B in Figure 6—figure supplement 2B) was eliminated (Figure 6—figure supplement 2D). These observations suggest that canonical Wnt signaling might directly regulate Imp1 expression.
To assess whether Imp1 expression is regulated by canonical Wnt signaling under physiological conditions we examined the telencephalons of Apc mutant mice (hGFAP-Cre; Apcflox/flox) to assess the consequences of increased Wnt signaling and ß-catenin mutant mice (Nestin-Cre; Ctnnb1flox/flox) to assess the consequences of decreased Wnt signaling. Imp1 expression was increased in the dorsal telencephalon of Apc deficient mice and decreased in the dorsal telencephalon of ß-catenin deficient mice relative to littermate controls (Figure 7A,B). Wnt signaling therefore promotes Imp1 expression in the telencephalon in vivo.
To test whether there is a positive feedback between Imp1 and canonical Wnt signaling (Gu et al., 2008) in neural stem/progenitor cells, we assessed ß-catenin expression in uncultured E13.5 telencephalon and in cultured neurospheres by qPCR and by western blot. However, we did not detect a significant difference in ß-catenin expression between Imp1β-geo/β-geo and control cells (Figure 6—figure supplement 2E,F). We also did not detect a statistically significant difference in the stability of ß-catenin transcripts between Imp1β-geo/β-geo and control neurospheres (Figure 6—figure supplement 2G), suggesting that there is no positive feedback from IMP1 to ß-catenin in neural stem/progenitor cells. IMP1 therefore appears to act downstream of Wnt signaling. The similarity between the Imp1 expression pattern (Figure 1D) and the Wnt signaling gradient in the dorsal telencephalon (Machon et al., 2007; Mutch et al., 2010), the observation that Wnt signaling promotes Imp1 expression in the dorsal telencephalon in vivo (Figure 7A), and the similarity in the phenotypic consequences of reduced Imp1 function (Figures 2–6) and reduced Wnt signaling (Mutch et al., 2010) all suggest that IMP1 acts autonomously within stem cells in the dorsal telencephalon to potentiate the effects of Wnt signaling during pallial expansion.
To test whether let-7 regulates Imp1 expression in vivo we administered doxycycline for 5 days to wild-type and tetracyclin-inducible let-7 transgenic (ilet-7) mice (Zhu et al., 2011). IMP1 protein expression was reduced in telencephalon cells freshly isolated from E13.5 ilet-7 mice relative to controls, indicating that elevated expression of let-7 negatively regulates IMP1 expression (Figure 7C). In E13.5 ilet-7 telencephalon, the number of cells that incoporated a 1 hr pulse of BrdU and the number of Pax6+ neural progenitors were significantly reduced relative to controls, whereas the number of Tbr2+ neuronal progenitors and Tuj1+ neurons were significantly increased (Figure 7D,E). let-7 induction thus phenocopied the IMP1 loss-of-function, consistent with the conclusion that let-7 negatively regulates IMP1 expression.
To assess whether the elevated expression of let-7 affects neural stem cell function we cultured dorsal telencephalon cells from doxycyclin-treated E13.5 wild-type and ilet-7 mice. The percentage of cells that formed multipotent neurospheres, neurosphere size, and self-renewal potential were all significantly (p<0.01) reduced in ilet-7+ cells relative to control cells (Figure 7—figure supplement 1A–D). These data indicate that increased let-7 expression negatively regulates Imp1 expression and fetal neural stem cell self-renewal.
Since there are 10 let-7 family members that are thought to act redundantly to repress target gene expression (Roush and Slack, 2008), we used inducible Lin28a transgenic (Lin28a Tg) mice (Zhu et al., 2010) to test whether reduced expression of endogenous let-7s would increase IMP1 expression. Lin28a negatively regulates the expression of all mature let-7 microRNAs (Heo et al., 2008; Newman et al., 2008; Rybak et al., 2008; Viswanathan et al., 2008). We cultured E18.5 dorsal telencephalon cells or P60 lateral ventricle SVZ cells from doxycycline-treated wild-type or inducible Lin28a Tg mice and observed a significant reduction in endogenous let-7b expression in Lin28a Tg as compared to control neurospheres (p<0.01; sevenfold-reduction in Lin28a Tg E18.5 neurospheres and 14-fold reduction in P60 Lin28a Tg neurospheres; Figure 7—figure supplement 1E). IMP1 protein expression was elevated in Lin28a Tg neurospheres relative to control neurospheres at E18.5 but not at P60 (Figure 7F). Neurosphere size and the self-renewal of multipotent neurospheres were significantly (*p<0.01) increased in E18.5 Lin28a Tg compared to control neurospheres (Figure 7G–I). These data suggest that physiological let-7 expression reduces Imp1 expression and self-renewal potential in fetal but not adult neural stem cells. Since we did not detect Imp1 transcription or Imp1β-geo reporter expression in the postnatal forebrain (Figure 1D,F, Figure 1—figure supplement 1D,F,G), Imp1 expression is silenced postnatally by mechanisms independent of let-7 (Figure 7F).
We also generated a floxed allele of the linked microRNAslet-7b and let-7c2 (let-7b/c2fl; Figure 7—figure supplement 2) and conditionally deleted it from fetal neural stem/progenitor cells using Nestin-Cre (Nestin-Cre; let-7b/c2flox/flox). The percentage of cells that formed multipotent neurospheres, neurosphere size, and self-renewal potential did not significantly differ between Nestin-Cre; let-7b/c2flox/flox mice and littermate controls at E18.5 or P60 (Figure 7—figure supplement 1H–K, and data not shown). Expression of Imp1 and Hmga2 transcripts also did not significantly differ between telencephalon cells obtained from Nestin-Cre; let-7b/c2flox/flox mice and littermate controls (Figure 7—figure supplement 1L). This is consistent with the expectation that let-7 family members act redundantly to regulate gene expression (Roush and Slack, 2008) such that deletion of let-7b/c2 is not sufficient to change Imp1 expression or neural stem cell function.
Although the major effects of Lin28a are mediated by let-7, there are also let-7-independent effects (Cho et al., 2012; Wilbert et al., 2012). To ensure that the effects of Lin28a on Imp1 expression (Figure 7F) are really mediated by changes in the physiological levels of let-7 family microRNAs we independently addressed this issue by testing whether Imp1 expression is regulated by the let-7 binding sites in the 3′ untranslated region (UTR). We overexpressed either full-lengh Imp1 cDNA that contains all let-7 binding sites (the let-7 sensitive form) or a truncated Imp1 cDNA that lacks the 3′-UTR (the let-7 insensitive form) in E12.5 telencephalon cells or P60 SVZ cells. We were able to over-express either form of IMP1 in the E12.5 cells, when let-7 expression is low, but in P60 SVZ cells higher levels of IMP1 were expressed from the truncated Imp1 cDNA that lacks the let-7 binding sites (Figure 7J). Ectopic expression of the let-7 insensitive form of Imp1, but not the let-7 sensitive form, significantly increased self-renewal and significantly reduced the number of differentiated neurons that arose in culture from neurospheres cultured from P60 SVZ (Figure 7K, Figure 7—figure supplement 1F,G). Over-expression of either form of Imp1 did not significantly affect self-renewal in E12.5 telencephalon cells (Figure 7K). Regulation of IMP1 expression and neural stem cell function requires let-7 binding sites in the Imp1 3′-UTR when let-7 microRNA expression levels are elevated in vivo.
To investigate the mechanism by which IMP1 promotes stem cell self-renewal we identified target RNAs bound by IMP1 in neural stem/progenitor cells. To do this we overexpressed FLAG-tagged IMP1 in neurospheres cultured from E13.5 Imp1β-geo/β-geo telencephalon then immunoprecipitated IMP1 and its target RNAs using an anti-FLAG antibody. When these RNAs were identified by deep-sequencing we found transcripts from 103 genes that were significantly enriched in the immunoprecipitated fraction compared with total RNA (three samples per genotype, >twofold-enrichment, p<0.05) (Supplementary file 1A). Many of these gene products are associated with differentiated cells and their expression increased in the telencephalon between E13.5 and E18.5 (as IMP1 expression declined) (Figure 8—figure supplement 1A) and in cultured neurospheres as differentiation progressed (Figure 8—figure supplement 1B). We could not detect a significant change in the expression of these genes by qPCR in Imp1-deficient neurospheres (Figure 8A), but did observe increased expression of several proteins against which effective antibodies were available (Figure 8B). We also detected a significant shift of these transcripts to the polysomal fraction in Imp1-deficient neurospheres (Figure 8C, Figure 8—figure supplement 1C). These data suggest that IMP1 acts post-transcriptionally to negatively regulate the expression of some proteins associated with neural differentiation.
Two let-7 microRNA targets that promote neural stem cell self-renewal, Hmga2 and cyclin D2 (Ccnd2), were also significantly enriched in the fraction bound by IMP1 (Supplementary file 1A). Ccnd2 expression was reduced in the dorsomedial telencephalon of Imp1 deficient mice (Figure 6B). To assess whether IMP1 regulates Hmga2 expression we compared the levels of Hmga2 and it’s family member Hmga1 by qPCR in E13.5 and E18.5 dorsomedial and dorsolateral telencephalon cells from Imp1β-geo/β-geo mice and littermate controls. Hmga2, but not Hmga1, transcript levels were significantly (p<0.05) reduced in Imp1β-geo/β-geo cells by qPCR (Figure 8D). This reduction in Hmga2 expression was also confirmed at the protein level by western blot (Figure 8E). In sections from Imp1β-geo/β-geo mice, the reduction in Hmga2 expression was confirmed by in situ hybridization in the dorsomedial and dorsolateral telencephalon (where Imp1 is normally expressed) but not in the ventral telencephalon (where Imp1 is not normally expressed; compare Figure 8F to Figure 1—figure supplement 1B,E). Indeed, the region of the dorsal telencephalon in which Hmga2 expression declined (Figure 8F) corresponded precisely with the region of Imp1 expression (Figure 1D). This demonstrates that IMP1 acts autonomously within stem cells in the dorsal telencephalon to maintain HMGA2 expression.
IMP1 appears to promote HMGA2 expression by increasing the stability of its mRNA as we detected a significantly (p<0.05) accelerated decay of mRNA for Hmga2, but not Hmga1, in neurospheres cultured from E13.5 Imp1β-geo/β-geo mice as compared to wild-type controls (Figure 8G). HMGA2 did not appear to regulate Imp1 expression because Imp1 transcript levels were not affected by Hmga2 deficiency by either qPCR (Figure 8H) or in situ hybridization (Figure 8I).
We previously demonstrated that HMGA2 promotes neural stem cell self-renewal in the fetal telencephalon, partly by negatively regulating the expression of Ink4a, which encodes a cyclin-dependent kinase inhibitor (Nishino et al., 2008). Consistent with this, we detected significantly (p<0.05) increased Ink4a expression in neurospheres cultured from E18.5 Imp1β-geo/β-geo mice as compared to wild-type controls (Figure 8J). Over-expression of Hmga2 restored normal levels of Hmga2 protein in E18.5 Imp1β-geo/β-geo neurospheres (Figure 8K) and significantly increased their self-renewal potential (Figure 8L; p<0.05). IMP1 therefore promotes the self-renewal of fetal neural stem cells partly by promoting the expression of HMGA2. This suggests that part of the mechanism by which neural stem cells expand in the dorsal telencephalon in response to Wnt signaling is through IMP1-promoted HMGA2 expression, but that HMGA2 expression and neural stem cell expansion decline postnatally as a consequence of increased let-7 expression (Nishino et al., 2008) and a loss of IMP1 expression (Figure 1A).
IMP1 is one element of a network of heterochronic genes that regulates temporal changes in neural stem cell function throughout life (see Figure 9 for a graphical summary). Expression of the let-7 target, Imp1, by stem cells in the dorsal telencephalon (Figure 1, Figure 1—figure supplements 1B,E and 2) promoted the expansion of undifferentiated stem cells in response to Wnt signaling during fetal development. Wnt signaling promoted Imp1 expression in the dorsal telencephalon in a medial-lateral gradient (Figure 7A–B, Figure 6—figure supplement 2A–D) similar to the gradient in canonical Wnt signaling (Machon et al., 2007; Mutch et al., 2010). Imp1 deficiency reduced stem cell self-renewal potential (Figure 2F–I) and caused premature neuronal and glial differentiation (Figure 4), leading to stem cell depletion (Figures 2G, 3A–C) and reduced pallial expansion (Figure 2A,D). Therefore, IMP1 expression by stem/progenitor cells during forebrain development regulates the timing of neuronal and glial differentiation. The postnatal loss of IMP1 expression may contribute to the decline in neural stem cell function during adulthood.
As let-7 expression increases during late fetal development (Figure 1B), Imp1 expression declines (Figure 1D). Increasing let-7 expression in neural stem cells reduces IMP1 expression (Figures 1C and 7C), the number of neural stem cells, and their self-renewal potential (Figure 7D–E, Figure 7—figure supplement 1A–D). Reducing the expression of mature let-7 microRNAs by inducing Lin28a expression increases IMP1 expression and neural stem cell self-renewal (Figure 7F–I). The let-7 binding sites in the Imp1 3′UTR impede IMP1 expression in adult neural stem cells (Figure 7J–K). Nonetheless, let-7 is not solely responsible for the perinatal loss of Imp1 expression as β-geo expression in Imp1β-geo/+ mice is also lost perinatally even though β-geo does not carry the Imp1 3′ UTR that contains the let-7 binding sites. Increasing expression of let-7 microRNAs during fetal development reduces IMP1 expression before other mechanisms silence Imp1 postnatally.
IMP1 is not detectably expressed in the adult forebrain (Figure 1A, Figure 1—figure supplement 1) and reduced let-7 microRNA expression does not restore IMP1 expression in adult neural stem cells (Figure 7F). IMP1 is also dispensable for the regulation of self-renewal in adult neural stem cells (Figure 2—figure supplement 2D–F). IMP1 is therefore required for the regulation of fetal but not adult neural stem/progenitor cells and contributes to the increased proliferation of undifferentiated cells in the fetal as compared to the adult forebrain. let-7 regulates the function of stem cells in the fetal and adult forebrains (Zhao et al., 2010); however, let-7 microRNAs appear to regulate different targets at different ages in neural stem cells. let-7 microRNAs, IMP1, and HMGA2 are three important elements of a network of heterochronic genes that regulates temporal changes in stem cell function throughout life.
Imp2 and Imp3 exhibit similar expression patterns as Imp1 (Figure 1—figure supplement 1H,I). The overlap in expression among IMP family members suggests potential redundancy among family members in stem cells from the dorsal telencephalon. This raises the question of whether compound deletion of multiple family members would further accelerate stem cell depletion.
IMP1 is known to increase the levels of some proteins by increasing the stability of their mRNAs (Noubissi et al., 2006) and to reduce the levels of other proteins by inhibiting translation (Hansen et al., 2004; Atlas et al., 2007). Consistent with this, IMP1 post-transcriptionally reduced the levels of some proteins associated with differentiation (Figure 8A–C, Figure 8—figure supplement 1A–C) while promoting the expression of the self-renewal factor, HMGA2 (Figure 8D–F). IMP1 appeared to promote HMGA2 expression by increasing the half-life of Hmga2 mRNA (Figure 8G), leading to higher levels of HMGA2 (Figure 8E) and lower levels of p16Ink4a (Figure 8J). We showed previously that HMGA2 promotes, and p16Ink4a inhibits, stem cell self-renewal in the telencephalon (Nishino et al., 2008). The postnatal lack of IMP1 expression in forebrain neural stem cells (Figure 1D, F, Figure 1—figure supplement 1D,F,G) is therefore likely to contribute to their reduced HMGA2 expression and self-renewal potential.
Recently, two genome-wide studies in HEK293 cells suggested the existence of putative IMP1 recognition sequences: 5′-CAUH-3′ (H = A, U, or C) (Hafner et al., 2010) and 5′-CCYHHCC-3′ (Y = C, U and H = A, C, U) (Jønson et al., 2007). We found these sequences at least once in all of our IMP1 pulled-downed mRNAs, but since these sequences would be expected to occur by chance in the mRNAs, no conclusion can be drawn regarding the functional relevance of these binding sites in the mRNAs we observed.
Recently, Imp (a fly ortholog of mammalian Imp1) was shown to non-cell-autonomously regulate the aging of germline stem cells in the fly testis (Toledano et al., 2012). This raises the possibility that IMP1 might have non-cell-autonomous effects on mammalian stem cells, at least in certain contexts. Indeed, the overall growth retardation observed in Imp1-mutant mice (Figure 2—figure supplement 1A) could reflect non-cell-autonomous effects of Imp1 deficiency. Nonetheless, our data indicate that IMP1 cell-autonomously regulates neural stem cell function in the dorsal telencephalon. First, neural stem cell specific knockdown of Imp1 in a small percentage of cells in the developing telencephalon reduced cell proliferation and accelerated differentiation in a cell autonomous way (Figure 5) .Second, all of our experiments demonstrating neural stem/progenitor cell phenotypes in Imp1 deficient (Figures 2F–I and 4), Lin28 transgenic (Figure 7G–I) or ilet-7 transgenic mice (Figure 7—figure supplement 1A–D) involved studies of individual isolated neural stem cells in culture. Third, in all of our experiments that involved viral infection (Figure 2—figure supplement 2B,C, Figures 6E–F, 7K, 8L, Figure 7—figure supplement 1F–G), we compared the growth of infected neurospheres to non-infected neurospheres growing in the same cultures, or in control cultures. We never observed non-cell autonomous effects of infected neurospheres on non-infected neurospheres within the same cultures. Finally, we observed a correlation between Imp1 expression and function within the telencephalon: the phenotypes observed in Imp1 deficient mice were consistently more profound in the dorsomedial telencephalon, where Imp1 expression was high, than in the dorsolateral telencephalon, where Imp1 expression was low (Figures 2E and 3, Figure 4B). IMP1 therefore cell-autonomously regulates the function of neural stem/progenitor cells in the dorsal telencephalon, but likely has non-cell-autonomous effects in other contexts.
We have thus demonstrated a novel function of the let-7 microRNA target, IMP1, to promote the expansion of neural stem cells during cortical development. let-7b also negatively regulates the self-renewal of adult neural stem cells by reducing the expression of Hmga2 (Nishino et al., 2008) and TLX (Zhao et al., 2010). This is consistent with our conclusion that a network of let-7 gene targets regulates stem cell function and that the regulation of different targets at different ages by let-7 contributes to temporal changes in stem cell properties.
Other RNA binding proteins also regulate stem cell function. FBF proteins and GLD proteins control germline stem cell maintenance and the timing of meiosis in C. elegans (Kimble and Crittenden, 2007). The evolutionarily conserved Piwi family proteins that bind to Piwi-interacting RNAs are also required for the maintenance of germline stem cells (Juliano et al., 2011). Musashi proteins appear to promote the self-renewal of fetal and adult stem cells from multiple tissues by translational repression of target RNAs (Sakakibara et al., 2002; Okano et al., 2005; Kharas et al., 2010). Lin28 is preferentially expressed by embryonic cells and essential for the development of primordial germ cells (West et al., 2009; Viswanathan and Daley, 2010). Indeed, the decline in Lin28 expression with time during fetal development may contribute to the increase in let-7 expression and the decline in IMP1 expression.
A network of heterochronic genes including let-7 microRNAs, Imp1, Hmga2, and the cell cycle regulators cyclin D and p16Ink4a, regulates temporal changes in stem cell function. While we have demonstrated the functional importance of this network in neural stem cells, this network is also likely to regulate temporal changes in stem cells from other tissues. Beyond the network components we identified, many additional let-7 target genes are likely to regulate developmental changes in stem cells, integrating stem cell properties with changing tissue growth and regeneration demands throughout life.
Imp1β-geo/+ (Hansen et al., 2004) (MMRRC stock number 011720-UCD), APCflox/+ (Shibata et al., 1997), β-catenin flox/+ (Brault et al., 2001), human-GFAP Cre (Malatesta et al., 2003), Lin28a transgenic (Zhu et al., 2010), ilet-7 transgenic (Zhu et al., 2011), Nestin-Cre (Tronche et al., 1999), Hmga2+/− mice (Zhou et al., 1995), and let-7b/c2 fl/+ mice were each backcrossed at least six times onto a C57BL/Ka background and housed at the University of Michigan Unit for Laboratory Animal Medicine or the University of Texas Southwestern Medical Center Animal Resource Center. Mice were genotyped by PCR. For let-7 or Lin28 induction, mice were administered water containing 2 μg/ml doxycycline (Research Products International Co., Mount Prospect, IL) for 4 to 5 days.
CNS progenitors were isolated as described in prior studies (Molofsky et al., 2005; Nishino et al., 2008). For adherent cultures, CNS progenitors were plated at a clonal density of 0.66 cells/μl (1000 cells per 35 mm well) in 6-well plates (Corning, Tewksbury, MA) that had been sequentially coated with 150 μg/ml poly-d-lysine (Biomedical Technologies, Stoughton, MA) and 20 μg/ml laminin (Sigma, St. Louis, MI). For the non-adherent culture of neurospheres, CNS progenitors were plated at a density of 1.33–2.67 cells/μl (2000–4000 cells per 35 mm well) in ultra-low binding 6-well plates (Corning). Cells were initially cultured for 7 to 9 days in ‘self-renewal medium’ to promote the formation of undifferentiated colonies. This medium was a 5:3 mixture of DMEM-low:neurobasal medium, supplemented with 20 ng/ml recombinant human bFGF (R&D Systems, Minneapolis, MN), 20 ng/ml epidermal growth factor (EGF) (R&D Systems), 10% chick embryo extract (CEE; made as described [Stemple and Anderson, 1992]), 1% N2 supplement (GIBCO, Grand Island, NY), 2% B27 supplement (GIBCO), 50 mM 2-mercaptoethanol, and penicillin/streptomycin (BioWhittaker, Walkersville, MD). After 7–9 days in self-renewal medium, cultures were fed with ‘differentiation medium’ and allowed to grow for an additional 4 to 6 days. Differentiation medium contained 10 ng/ml of bFGF (instead of 20 ng/ml), 5% fetal bovine serum (GIBCO), no EGF, and no CEE. After being grown in self-renewal medium, neurospheres were transferred to adherent cultures containing differentiation medium before being stained to assess multilineage differentiation. When Lin28a Tg neurospheres were cultured, 2 µg/ml doxycycline were added to the culture medium to sustain Lin28 transgene expression. All cultures were maintained at 37°C in 6% CO2 incubators.
To quantify self-renewal potential, individual CNS neurospheres were dissociated by trituration then replated at clonal density (1.33 cells/μl) in nonadherent secondary cultures. Secondary neurospheres were counted 7 to 9 days later, then transferred to adherent cultures containing differentiation medium to measure the percentage of secondary neurospheres that could undergo multilineage differentiation.
For viral infection (sometimes lentivirus and sometimes retrovirus, depending on the experiment), CNS progenitors were plated at a high density of 10 cells/μl and cultured adherently in self-renewal medium. After 48 hr, viral supernatant was added for 24 hr then switched to fresh self-renewal medium for a further 24 hr. Cells were harvested by incubating for 1.5 min at 37°C in trypsin/EDTA and transferred to nonadherent cultures to form neurospheres for 7 days.
To measure mRNA decay, neurospheres formed by cells dissected from E13.5 dorsal telencephalon were plated adherently and cultured for 2 days in self-renewal medium. Then fresh self-renewal medium with 10 μg/ml Actinomycin D was added and the cells were harvested at the indicated time points to examine mRNA levels by quantitative RT-PCR.
For explant cultures, pieces of E12.5 wild-type dorsolateral telencephalon were placed onto transwell plates (6.5 mm with 8.0 µm Pore Polycarbonate Membrane Insert, Corning) and cultured for 12 hr with ‘explant culture medium’ (a 5:3 mixture of DMEM-low:neurobasal medium, 1% N2 supplement, 2% B27 supplement, 50 mM 2-mercaptoethanol, and penicillin/streptomycin) supplemented with or without recombinant mouse Wnt-3a (100 ng/ml, R&D Systems), recombinant mouse Dkk-1 (200 ng/ml, R&D Systems), or recombinant mouse BMP-4 (100 ng/ml, R&D Systems).
To generate let-7b flox/flox mice, bacterial artificial chromosome (BAC) clones containing the let-7b/c2 genomic locus were purchased (Invitrogen, Grand Island, NY) and a targeting vector was constructed using bacterial recombineering (Copeland et al., 2001; Liu et al., 2003). In this construct, the let-7b/c2 genomic locus was flanked by loxP elements (see Figure 7—figure supplement 2). Neomycin resistance, diphtheria toxin fragment A (DT-A), and thymidine kinase cassettes were included for positive and negative selection. Bruce 4.G9 ES cells were electropolated with the targeting construct, positively selected with G418 (Gibco), and negatively selected with gancyclovir (cytovene from Syntex). Correctly targeted ES cells were identified by Southern blot and their karyotypes were assessed. Three independent euploid ES cell clones were injected into blastcysts obtained from B6(Cg)-Tyrc-2j/J mice (Jackson Laboratory, Bar Harbor, ME). The resulting male ES cell/mouse chimeras were bred with B6(Cg)-Tyrc-2j/J mice to obtain germline transmission. After germline transmission, the neo cassette was removed by crossing with B6.Cg-Tg(ACTFLPe)9205Dym/J mice (Rodriguez et al., 2000). Conditional let-7b/c2 mutant mice (Nestin-Cre; let-7b/c2flox/flox) were obtained by breeding Nestin-Cre mice (Tronche et al., 1999) with let-7b/c2 flox/+ mice.
CNS neurospheres formed by cells dissected from E13.5 Imp1β-geo/β-geo dorsal telencephalon were infected with pMIG-3XFLAG-Imp1 retrovirus. Immunoprecipitation of Imp1-FLAG fusion protein along with the mRNAs it bound was done using an RIP-Assay kit (MBL, Woburn, MA) according to the manufacturer’s instructions. Briefly, neurospheres were washed with ice cold-PBS and lysed in buffer containing proteinase inhibitor cocktail (Sigma) and RNAse inhibitor (Roche, Madison, WI) on ice for 15 min. After clearing cell debris by centrifugation, supernatants were incubated with Protein G-Agarose for 60 min to absorb non-specific binding.
After eliminating Protein G-Agarose by centrifugation, small fractions of supernatants were saved as input, and the rest was incubated for 3 hr with anti-FLAG M2 Affinity Gel (Sigma). Immunoprecipitated fractions were washed with washing buffer and RNAs were eluted with solution Ⅰ-ⅠⅤ, precipitated with ice-cold 2-propanol, washed with ice-cold ethanol, and suspend in RNAse free water according to the RIP-Assay kit manufacturer’s instructions (MBL). cDNA synthesis and library construction were performed using Ovation RNA-Seq System V2 and Encore NGS Library System Ⅰ (Part Numbers 7102 and 300; NuGEN Technologies, Inc., San Carlos, CA) following the manufacturer’s instructions. We used 100 ng total RNA from the FLAG immunoprecipitated fraction or input fraction from three independent experiments. Briefly, first strand cDNAs were synthesized by incubating RNAs with first strand reagents in the Ovation RNA-Seq System V2 kit by incubating at 65°C for 5 min, 4°C for 1 min, 25°C for 10 min, 42°C for 10 min, 70°C for 15 min. Second strand cDNAs were generated by incubating with second strand reagents in the Ovation RNA-Seq System V2 kit at 4°C for 1 min, 25°C for 10 min, 50°C for 30 min, 80°C for 20 min. Primers and nucleotides were eliminated from purified cDNAs by mixing with Agencourt RNAclean XP purification beads (Beckman coulter) followed by magnetic separation on a 96-well magnetic plate (ALPAQUA) for 5 min cDNA was amplified by incubating with SPIA reagents in the Ovation RNA-Seq System V2 kit at 4°C for 1 min, 47°C for 60 min, and 80°C for 20 min.
Amplified cDNAs were quantified with Quant-iT PicoGreen dsDNA reagent and kits (Molecular probes Inc., Eugene, OR), and sheared to 150–200 bp fragments using a Covaris S220 ultra-sonicator (Covaris, Woburn, MA) at 10% duty cycle, intensity set at 5, 100 cycles/burst for 5 min. Sheared cDNAs were then endo-repaired by incubating with endo-repair reagents in the Encore NGS Library System Ⅰ kit at 25°C for 30 min, 70°C for 10 min. Primers and nucleotides were eliminated from cDNAs by mixing with Agencourt RNAclean XP purification beads (Beckman coulter, Brea, CA) followed by magnetic separation on a 96-well magnetic plate (ALPAQUA, Beverly, MA) for 5 min. Next adaptors were ligated by incubating with ligation adaptor reagents in the Encore NGS Library System Ⅰ kit at 25°C for 10 min, then cDNAs were amplified by incubating with amplification reagents in the same kit at 72°C for 2 min, followed five cycles at 94°C for 30 s, 55°C for 30 s, 72°C for 1 min, 10 cycles at 94°C for 30 s, 63°C for 30 s, 72°C for 1 min, and 72°C for 5 min.
cDNA libraries were sequenced to 50-fold coverage using a Hiseq 2000 Sequencing System (Illumina, Inc., San Diego, CA). The raw sequence data were assessed for quality using FASTQC software (http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/) and aligned to the mouse reference genome MM9 (build 37) using TopHat (Langmead et al., 2009; Trapnell et al., 2009). Differences in RNA abundance were assessed using the CuffDiff algorithm in the CuffLinks software (Roberts et al., 2009; Trapnell et al., 2010). Parameter settings were: fragment-bias-correct (mm9.fa), compatible-hits-norm, multi-read-correct, and upper-quartile-norm. Using a locally derived perl script, we selected genes as being differentially expressed if they showed test status ‘OK’, FDR <= 0.05, and fold-change of at least 2.0.
E12.5-E18.5 dorsal telencephalons were removed and dissociated by incubating for 4 min at 37°C in 0.5 ml/ml DNAse1 (Sigma) in Ca, Mg-free HBSS, and resuspended in staining medium: L15 medium (Gibco) containing 1 mg/ml BSA (Sigma A-3912, St. Louis, MO), 10 mM HEPES (pH7.4) and penicillin/streptomycin (BioWhittaker, Walkersville, MD). After centrifuging (200×g for 4 min), the cells were gently triturated, filtered through nylon screen (45 nm, Sefar America, Kansas City, MO), counted by hemocytometer, and plated.
E12.5 or E14.5 timed-pregnant female C57BL/6 mice were anesthetized with isofluorane and their uteri were exposed. 0.5–1 μl of lentiviral supernatant, including 10 μg/ml Polybrene (Millipore) and 0.05% fast green (Sigma F-7258, St. Louis, MO), were delivered into the lateral ventricle of telencephalons of each embryos using glass capillaries. After injection, uteri were placed back into the abdomen and the wounds were closed with surgical sutures (Tevdek Ⅱ 3-0, DEKNATEL, Gurnee, IL). Three days later, embryos were fixed and sectioned for immunostaining.
CNS neurospheres were tested for multipotency by replating one neurosphere per well of 48-well plates coated with poly-d-lysine and laminin. The adherent neurospheres were allowed to differentiate for 4 to 6 days, then incubated first in anti-O4 antibody (1:800 ascites, Developmental Study Hybridoma Bank, Iowa city, IA), and then fixed in acid ethanol (5% glacial acetic acid in 100% ethanol) for 20 min at −20°C. After blocking and washing, the cultures were stained in donkey anti-mouse-IgM secondary antibody conjugated to horse radish peroxidase (Jackson Immunoresearch, West Grove, PA), followed by Nickel diaminobenzidine staining. Then cultures were stained with Tuj1 (1:500 Covance, Princeton NJ) and anti-GFAP (1:200, Sigma G-3893) primary antibodies followed by Alexa-Fluor 488 or 555 conjugated goat anti-mouse IgG1 and goat anti-mouse IgG2a secondary antibodies (1:1000 each, Molecular Probes Inc., Eugene, OR).
For analyses of cell proliferation in culture, cells were pulsed with 10 μM BrdU (Sigma) for 20 min, fixed in 70% ethanol for 30 min at −20°C, and stained with an anti-BrdU antibody (1:200 Caltag, Burlingame, CA) overnight at 4°C. Alexa-Fluor 488 conjugated goat anti-mouse IgG2a secondary antibody (Molecular Probes; 1:1000) was then stained for 1 hr at room temperature. For caspase-3 staining, cultures were fixed for 10 min at room temperature in 4% paraformaldehyde, blocked, then stained with an anti-activated caspase 3 antibody (1:1000, Pharmingen, San Diego, CA) overnight at 4°C. Alexa-Fluor 555 conjugated goat anti-rabbit IgG secondary antibody (Molecular Probes; 1:1000) was then stained for 1 hr at room temperature. In all cases, cell were counter stained for 10 min at room temperature with 10 μg/ml DAPI (Sigma D-8417).
For X-gal staining of neurospheres, E12.5 or E18.5 CNS neurospheres were fixed with 1% paraformaldehyde plus 0.2% glutaraldehyde for 5 min at 4°C, and incubated for 1 hr at 37°C in staining solution: PBS containing 2 mM 5-bromo-4-chloro-3-indolyl-beta-D-galactosidase (X-dgal; Molecular Probes, Eugene OR, USA), 2 mM MgCl2, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, and 0.02% NP-40. In some cases, neurospheres were fixed with 4% paraformaldehyde for 10 min at 4°C, cryoprotected in 30% sucrose, embedded in OCT compound (Sakura Fineteck Inc., Torrance, CA) and frozen. Then 10 μm sections were cut and stained with chick anti-beta-galactosidase antibody (1:2000, BGL-1040, Aves Labs Inc., Tigard, OR) and anti-nestin antibody (1:400, MAB353, Millipore, Billerica, CA). Alexa-Fluor 488 conjugated goat anti-mouse IgG2a secondary antibody (Molecular Probes; 1:1000) was then stained for 1 hr at room temperature.
Brains were fixed in 4% paraformaldehyde at 4°C overnight, cryoprotected in 30% sucrose, embedded in OCT compound, and frozen. 12 μm sections were cut, then pre-blocked for at least 1 hr at room temperature in blocking solution (PBS containing 5% goat serum, 0.2% bovine serum albumin, and 0.5% Triton X-100), incubated with primary antibody at 4°C overnight, followed by washing, and incubation in secondary antibody for 1 hr at room temperature. For some antigens (Ki67, BrdU), sections were boiled before blocking in 10 mM sodium citrate (pH 6.0) for 10 min to retrieve antigens. Sections were counter stained in 2.5 μg/ml DAPI for 10 min at room temperature, then mounted using ProLong antifade solution (Molecular Probes Inc., Eugene, OR). Primary antibodies included those against beta-galactosidase (1:2000), Tuj1 (1:1000), phospho-Histone H3 (Cell Signaling Technology Inc., Danvers, MA, 1:200), Pax6 (1:1000, Millipore, Billerica, MA), Tbr2 (1:200, Abcam, Cambridge, MA), GFAP (1:100,0, DAKO, Carpinteria, CA), Cyclin D1 (Thermo Scientific, Fremont, CA, 1:200), BrdU (1:200, Accurate Chemical, Westbury, NY), Ki67 (1:200, clone B56, BD Biosciences, San Jose, CA), and TAG-1 (1:400 ascites, Developmental Study Hybridoma Bank, University of Iowa, Iowa city, IA). For secondary antibodies, Alexa-Fluor 488 or 555 or 647 conjugated antibodies were used (1:1000 each, Molecular Probes Inc., Eugene, OR). TUNEL staining was performed using the Apoptag fluorescein In Situ Apoptosis Detection kit (Millipore).
For cell cycle exit analysis, E13.5 pregnant dams were injected intraperitoneally with 50 mg BrdU/kg body mass. 24 hr later, E14.5 pups were dissected and brains were fixed and processed as described above. For X-gal staining, E10.5-E12.5 mouse embryos or E14.5-P0 brains were fixed with 1% paraformaldehyde plus 0.2% glutaraldehyde for 15 min at 4°C. Then whole brains or cryosections were incubated in staining solution at 37°C for 4 to 16 hr as described above.
For in situ hybridization to Imp1 and Hmga2 transcripts in tissues, brains were fixed in 4% paraformaldehyde at 4°C overnight, cryoprotected in 30% sucrose, embedded in OCT, and frozen. 12 μm sections were cut, pretreated with 2 μg/ml Proteinase K at 37°C for 20 min, with 0.2N HCl for 10 min at room temperature, with 0.1M triethanolamine-HCl for 10 min at room temperature and Digoxigenin-labeled antisense probe at 55°C overnight. The next day, sections were washed with 2 × SSC for 30 min at 55°C, with 0.2 × SSC for 40 min at 55°C, blocked with 20% goat serum for 1 hr, and incubated with anti-Digoxigenin-labeled-AP (Alkaline phosphatase) Fab fragment (1:2000, Roche) for 60 min at room temperature. Sections were washed with Tris buffered saline (pH 9.5) with 0.1% Tween-20 for 30 min at room temperature, and incubated with 0.5 μl/ml NBT (nitro-blue tetrazolium chloride) plus 3.5 μl/ml BCIP (5-Bromo-4-Chloro-3′-Indolylphosphatase p-Toluidine salt) (Roche).
Cells or tissues were resuspended in ice-cold cell lysis buffer (Cell Signaling Technology, Danvers, MA) with protease inhibitor cocktail (Sigma), and incubated for 20 min on ice. SDS PAGE was done in 4–20% Tris-Glycine Gels (Invitrogen) and transferred to PDVF membranes (Millipore). The membranes were blocked in Tris buffered saline with 0.05% Tween-20 and 5% milk powder, incubated with primary and secondary antibodies, and washed following standard procedures. Horse radish peroxidase conjugated secondary antibodies were detected by Supersignal West Femto Chemiluminescent Sustrate (Pierce). Primary antibodies were rabbit anti-IGF2BP/IMP1 (MBL, 1:2000), mouse anti-β-Catenin (1:2500, BD Biosciences), mouse anti-Synaptotagmin 1 (Abcam, 1: 2000), rabbit anti-LRRTM2 (1:2000), mouse anti-UNC5D (Abcam, Cambridge, MA, 1:1000), rat anti-OMgp (1:2500, R&D Systems), rabbit anti-HMGA2 (1:2000, a generous gift from M Narita and S Lowe), mouse anti-FLAG (Sigma, M2 1:5000), human anti-ribosomal P antigen (Immunovision, Springdale, AR, 1: 20000), and mouse anti-α-tubulin (1:10000, Sigma).
Quantitative RT-PCR was performed as described previously (Nishino et al., 2008). Primers used for amplification are listed in Supplementary file 1B. For let-7b, small RNAs (<200 nt) were extracted with mirVana miRNA isolation kit (Ambion, Grand Island, NY), and RT-PCR was performed with specific primers and probes supplied in Taqman MicroRNA Assay kits (Applied Biosystems, Grand Island, NY).
The Imp1-GFP vector was constructed by subcloning mouse Imp1 cDNA (corresponding to NCBI NM_009951 from 312 to 7455, including the Imp1 ORF and let-7 binding sites in the 3′-UTR but lacking the polyadenylation signal) with N-terminal 3XFLAG into Bgl2-XhoI sites of the retroviral vector pMIG (MSCV-IRES-GFP). For Imp1 (3′-UTR del)-GFP vector construction, the Imp1 ORF (NCBI NM_009951 from 312 to 2045) was used instead. For Imp1-β-geo fusion protein+GFP vector construction, the 5′-fragment of Imp1 ORF (NCBI NM_009951 from 312 to 547) and β-geo ORF were subcloned with N-terminal 3XFLAG into Bgl2-XhoI sites of retroviral vector pMIG. The CyclinD1-GFP vector was constructed by subcloning mouse cyclin D1 ORF (NCBI NM_007631 from 233 to 1120) into the EcoRl site of the retroviral vector pMIG. Constructs for let-7b or Hmga2 were described previously (Nishino et al., 2008). Viral supernatants were prepared by co-transfecting proviral plasmids and packaging vectors (pCL-Eco and pC1-VSVG) into 293T cells by standard calcium phosphate precipitation methods. The supernatant was collected after 72 hr and incubated with Retro-X Concentrator (Clontech, Mountain View, CA) at 4°C overnight. The next day, a viral pellet was obtained by centrifugation at 1,500×g in a Beckman JS 5.3 rotor for 45 min at 4°C and resuspended in a 5:3 mixture of DMEM-low:neurobasal medium for addition to culture medium.
CNS neurospheres were formed by non-adherently culturing E12.5 wild-type dorsal telencephalon cells. The neurospheres were then plated adherently on 100 mm dishes coated with poly-d-lysine and laminin, and cultured in self-renewal medium (see above for composition) for additional 2 days. ChIP was done using the EZ ChIP Chromatin Immunoprecipitation kit (Upstate, Billeria, CA) according to the manufacturer’s instructions. Briefly, cells were fixed with 1% paraformamide for 10 min at room temperature, washed with ice cold PBS, and lysed in SDS lysis buffer supplemented with protease inhibitor cocktail. Then DNA was sheared using a sonicator (Virsonic 100, VirTis Inc., Warminster, PA), and incubated with Protein G-Agarose for 60 min at 4°C to absorb non-specific binding. After eliminating Protein G-Agarose by centrifugation, small fractions of supernatants were saved as input, and the rest were incubated overnight at 4°C with either monoclonal anti-TCF4 antibody (clone 6H5-3, Millipore) or normal mouse IgG (supplied in EZ ChIP kit). The next day, immunoprecipitated fractions were collected by incubating with Protein G-Agarose for 60 min at 4°C, washed with washing buffer, eluted with elution buffer, and reverse-crosslinked in 0.2 M NaCl at 65°C overnight. Then DNA was purified using an affinity column, and subjected to PCR. PCR primers are listed in Supplementary file 1B.
An Imp1 genomic DNA fragment (corresponding to −1980 to +1 base pairs in Figure 5—figure supplement 1) was subcloned into pBluesript SK(+) (Stratagene, La Jolla, CA), then site A (from −1906 to −1901 bp), site B (from −487 to −481 bp), or both site A and site B were eliminated by PCR. Intact or mutated fragments were subcloned into pGL3-Vector (Promega, Madison, WI) to generate luciferase reporter plasmids. These reporter plasmids, TOPflash (Millipore), or empty pGL3-Vector were mixed with pRL-TK vector (Promega) at a 10:1 ratio, and transfected to P19 embryonic carcinoma cells (ATCC) using lipofectamine 2000 (Invirogen). After transfection for 36 hr, cells were exposed to medium supplemented with 20 mM LiCl and cultured for an additional 12 hr. A dual luciferase assay was conducted using Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer’s instructions. Briefly, cells were washed with PBS, and lysed in 1X passive lysis buffer at ambient temprature for 20 min. Cell lysates were mixed with Luciferase Assay Reagent Ⅱ and firefly luciferase activity was measured by microplate reader (FLUOstar Omega, BMG LABTECH, Cary, NC). Next, 1X Stop & Glo Reagent was added and mixed, and Renilla luciferase activity was measured.
CNS neurospheres were formed by non-adherently culturing E13.5 wild-type dorsal telencephalon cells then plated adherently on 100 mm dishes coated with poly-d-lysine and laminin, and cultured in self-renewal medium for an additional 2 days. Cells were treated with 0.1 μg/ml cycloheximide (Sigma) for 3 min, washed three times with PBS plus 0.1 μg/ml cycloheximide, and then lysed on ice for 15 min in polysome extraction solution (10 mM Tris [7.4], 15 mM MgCl2 ,0.3M NaCl, 1% Triton X-100, and 10 μg/ml heparin [Sigma]) plus 0.1 μg/ml cycloheximide. After clearing cell debris by centrifugation, small aliquots of lysates were saved as input controls and the rest were loaded on top of a 10–50% sucrose gradient in polysome extraction buffer plus 0.1 μg/ml cycloheximide, and spun down at 4°C at 35,000 rpm for 190 min in an SW41 rotor (Beckman Coulter). After ultracentrifugation, fractions were taken serially from the top (10% sucrose) to the bottom (50% sucrose). Each fraction was divided into half and either saved in Trizol (Invitrogen) for RNA extraction or subjected to methanol/chloroform protein extraction. To assess the shift of ribosomal proteins, parallel cultures were processed in solutions that contain 30 mM EDTA instead of cycloheximide.
Genotyping was performed by PCR following the manufacturer’s instructions using Go Taq Flexi DNA polymerase (Promega) for Imp1, Lin28a, let-7, Hmga2, and let-7b/c2 mutant mice and Choice-Taq DNA Polymerase (Denville Scientific Inc. Metuchen, NJ) for Apc, β-catenin, and Nestin-Cre mice. The PCR conditions for Imp1, Hmga2, and let-7b/c2 mutant mice were 94°C for 2 min, then 33 cycles of 94°C for 30 s followed by 60°C for 30 s and 72°C for 1 min, with 72°C for 2 min at the end. For Lin28a and let-7 inducible transgenic mice PCR genotyping conditions were 94°C for 2 min, then 35 cycles of 94°C for 30 s followed by 55°C for 30 s and 72°C for 1 min, with 72°C for 2 min at the end. For Apc mutant mice, 94°C for 3 min, then 34 cycles of 94°C for 1 min followed by 55°C for 1 min and 72°C for 2 min, with 72°C for 10 min at the end. For β-catenin mutant mice, 94°C for 3 min, then 34 cycles of 94°C for 1 min followed by 59°C for 1 min and 72°C for 2 min, with 72°C for 10 min at the end. For Nestin-cre, 94°C for 3 min, then 34 cycles of 94°C for 1 min followed by 63°C for 1 min and 72°C for 2 min, with 72°C for 10 min at the end. Primers used for genotyping are listed in Supplementary file 1B.
Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial developmentDevelopment 128:1253–1264.
Evidence for a mitogenic effect of Wnt-1 in the developing mammalian central nervous systemDevelopment 120:1453–1471.
Mechanisms of stem cell self-renewalAnn Rev Cell Dev Biol 25:377–406.https://doi.org/10.1146/annurev.cellbio.042308.113248
Molecular composition of IMP1 ribonucleoprotein granulesMol Cell Proteomics 6:798–811.https://doi.org/10.1074/mcp.M600346-MCP200
Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferationJ Neurosci 16:2027–2033.
A mitogen gradient of dorsal midline Wnts organizes growth in the CNSDevelopment 129:2087–2098.
Cytoplasmic trafficking of IGF-II mRNA-binding protein by conserved KH domainsJ Cell Sci 115:2087–2097.
A family of insulin-like growth factor II mRNA-binding proteins represses translation in late developmentMol Cell Biol 19:1262–1270.
Function of RNA-binding protein Musashi-1 in stem cellsExp Cell Res 306:349–356.https://doi.org/10.1016/j.yexcr.2005.02.021
Janet RossantReviewing Editor; University of Toronto, Canada
eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see review process). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.
Thank you for sending your work entitled “A network of heterochronic genes including Imp1 regulates temporal changes in stem cell properties” for consideration at eLife. Your article has been favorably evaluated by a Senior editor and 3 reviewers, one of whom, Leanne Jones, has agreed to reveal her identity.
The Senior editor, Janet Rossant, and the three reviewers discussed their comments before we reached this decision, and the Senior editor has assembled the following comments to help you prepare a revised submission.
Overall, the reviewers agreed that you have developed a strong set of data implicating the let7 target gene, Imp1, in neural stem cell proliferations during fetal brain development. However, there was a major concern with your conclusion that Imp1 was cell-autonomously required for NSC self-renewal, both in vitro and in vivo. You used the gene trap Imp1-βgeo knockout mouse, which shows overall growth defects throughout the embryo (and the placenta) by E17.5. Given that Imp1βgeo/βgeo neurospheres only showed self-renewal defects in vitro when isolated at E18.5 and not E12.5, this raises the possibility that the effects could be secondary. E18.5 is a time-point where the severe growth defects could have already affected the NSCs non-cell autonomously before isolation, perhaps due to a systemic reduction in IGF2 (Hansen et al., 2004). Given that WT Imp1 expression is highest at E12.5, but nearly extinguished in the WT brain by E17.5, one might have expected that defects would have been more likely in the early rather than the late neurospheres. The fact that you only observed NSC defects at E18.5 in Imp1βgeo/βgeo mice, in vitro and in vivo throughout the manuscript, leaves open the possibility that the effects could be completely explained by non-cell autonomous effects. In order to prove cell-autonomy, neural-specific deletion of a floxed Imp1 allele would be required. If you can undertake these experiments, this would strengthen your conclusions. If this experiment does not work, you would have to modify your claim of cell-autonomy. We understand that these experiments would take longer than two months unless you have already initiated the crosses.https://doi.org/10.7554/eLife.00924.024
Overall, the reviewers agreed that you have developed a strong set of data implicating the let7 target gene, Imp1, in neural stem cell proliferations during fetal brain development. However, there was a major concern with your conclusion that Imp1 was cell-autonomously required for NSC self-renewal, both in vitro and in vivo. You used the gene trap Imp1-βgeo knockout mouse, which shows overall growth defects throughout the embryo (and the placenta) by E17.5. Given that Imp1βgeo/βgeo neurospheres only showed self-renewal defects in vitro when isolated at E18.5 and not E12.5, this raises the possibility that the effects could be secondary. E18.5 is a time-point where the severe growth defects could have already affected the NSCs non-cell autonomously before isolation, perhaps due to a systemic reduction in IGF2 (Hansen et al., 2004). Given that WT Imp1 expression is highest at E12.5, but nearly extinguished in the WT brain by E17.5, one might have expected that defects would have been more likely in the early rather than the late neurospheres. The fact that you only observed NSC defects at E18.5 in Imp1βgeo/βgeo mice, in vitro and in vivo throughout the manuscript, leaves open the possibility that the effects could be completely explained by non-cell autonomous effects. In order to prove cell-autonomy, neural-specific deletion of a floxed Imp1 allele would be required. If you can undertake these experiments, this would strengthen your conclusions. If this experiment does not work, you would have to modify your claim of cell-autonomy. We understand that these experiments would take longer than two months unless you have already initiated the crosses.
There are several issues to address here. The first important point is that although Figure 2 showed that neurospheres had self-renewal defects at E18.5 and not at E12.5, this should not be taken to mean that neurospheres did not exhibit defects prior to E18.5. We simply had not tested cultured neurospheres at intermediate time points because we focused our analyses on more definitive in vivo experiments at the intermediate time points. To address this we performed two experiments in which we examined the frequency and self-renewal of multipotent neurospheres cultured from E15.5 Imp1 deficient and control telencephalon. We observed declines in the frequency and self-renewal of Imp1 deficient neurospheres in both experiments. We have added these new data to Figure 2G and H.
The second important point is that Imp1 does continue to be expressed within stem cells from the dorsomedial telencephalon through E18.5. Its expression is extinguished neonatally. The manuscript shows IMP1 expression in the VZ of the dorsal telencephalon at E14.5, E16.5 (Figure 1—figure supplement 1A, B) and in neurospheres cultured from the E18.5 dorsomedial telencephalon (Figure 7F). As requested, we have also summarized the expression pattern and the anatomy schematically in Figure 1–figure supplement 2.
The third important point is that it is not accurate that we only observed NSC defects at E18.5 in the Imp1βgeo/βgeo mice. A number of figures in our manuscript show that we observed significant neural stem cell defects in vivo beginning at E12.5. These defects were associated with significant changes in the numbers of Tbr2+ progenitors beginning at E12.5 (Figure 3E), the numbers of TuJ1+ neurons beginning at E12.5 (Figure 4B), the number of Pax6+ stem cells beginning at E14.5 (Figure 3B), the frequency of dividing cells beginning at E16.5 (Figure 2E), and the cortical surface length beginning at E16.5 (Figure 2D). The in vivo data demonstrate evidence of premature stem cell differentiation in vivo beginning at E12.5 and continuing throughout fetal development. There is no disconnect between the timing of Imp1 expression in these cells and the timing with which premature differentiation is observed in vivo.
We believe that certain phenotypes were not observed until E16.5 or E18.5 because loss of IMP1 function causes neural stem cells to prematurely differentiate first into Tbr2+ intermediate progenitors (first detected at E12.5, Figure 3E) and then into neurons (first detected at E12.5, Figure 4B) and glia (first detected at E18.5, Figure 4G). Since Tbr2+ intermediate progenitors are themselves dividing, this delays the onset of defects in proliferation and cortical growth, which were not observed until E16.5.
Unfortunately, nobody has ever made a floxed allele of Imp1, making it impossible for us to conditionally delete in neural stem cells. To address this we have instead injected virus bearing an shRNA against Imp1 into the forebrain of fetal mice developing in utero. We confirmed that this shRNA profoundly reduced Imp1 expression in cultured neurospheres (Figure 5A). By transilluminating the uterus we were able to inject virus into the E12.5–E14.5 telencephalic ventricle, infecting a small minority of stem cells in the dorsal telencephalon. At E15.5–E17.5, we compared Ki67, Pax6, Tbr2, and Tuj1 staining by cells infected (GFP+) with the Imp1 shRNA versus a control scrambled shRNA. Cells infected with the Imp1 shRNA were significantly less likely to express Pax6 or Ki67 and significantly more likely to express Tbr2 or Tuj1 (Figure 5C-F; Figure 5–figure supplement 1). This demonstrates that IMP1 acts cell autonomously within stem cells in the dorsal telencephalon to promote the maintenance of an undifferentiated state.
We agree that IMP1 is likely to have a mix of cell-autonomous and non-cell-autonomous effects on the growth of other tissues. We have acknowledged this in our manuscript; however, all of our data are consistent with cell-autonomous effects in the dorsal telencephalon.https://doi.org/10.7554/eLife.00924.025
- Sean J Morrison
- Sean J Morrison
- Sean J Morrison
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
This work was supported by the Cancer Prevention and Research Institute of Texas, the National Institute on Aging (R37 AG024945), the National Institutes of Neurological Disease and Stroke (NS40750), and the Howard Hughes Medical Institute. JN was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science. Thanks to Carla Green, Elain Shar, and Shihoko Kojima (University of Texas Southwestern Medical Center) for helping with the polysome analysis. Thanks to Brendan Tarrier (University of Michigan DNA Sequencing Core) for conducting NGS seqencing. Thanks to Richard McEachin (University of Michigan Center for Computational Medicine and Bioinformatics) and Zhiyu Zhao (University of Texas Southwestern Medical Center) for analysing NGS sequence data. Thanks to George Daley (Boston Children’s Hospital) for providing Lin28a transgenic and ilet-7 transgenic mice. Thanks to Rhonda Bassel-Duby (University of Texas Southwestern Medical Center) for providing pGL3 and pRL-TK vectors.
Animal experimentation: All mice used in this study were housed in the Unit for Laboratory Animal Medicine at the University of Michigan (UM) or in the Animal Resource Center at the University of Texas Southwestern Medical Center (UTSW). All procedures were approved by the UM Committee on the Use and Care of Animals (#8373) and by the UTSW Institutional Animal Care and Use Committee (2011-0104).
- Janet Rossant, University of Toronto, Canada
- Received: May 10, 2013
- Accepted: September 29, 2013
- Version of Record published: November 5, 2013 (version 1)
© 2013, Nishino et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.